Freya Pharma Solutions Announced Further Strengthening of its IP Position for Improved Treatment for Women Suffering From FSIAD

Freya Pharma Solutions Announced Further Strengthening of its IP Position for Improved Treatment for Women Suffering From FSIADAmsterdam, the Netherlands, 25 August 2022 - Freya Pharma Solutions, a late clinical stage pharmaceutical company focusing on the development of effective pharmaceutical therapies for women...

Related Keywords

Helsinki ,Eteläuomen Läi ,Finland ,Netherlands ,Amsterdam ,Noord Holland , ,Pharma Solutions ,European Union ,European Medicines Agency ,Freya Pharma Solutions ,Freya Pharma Solutions Announced Further ,Improved Treatment ,Women Suffering From ,Female Sexual ,Arousal Disorder ,Intellectual Property ,Good Clinical Practices ,Trial Regulation ,Member States ,Chief Medical Officer ,